Portage Biotech Inc. (PRTG)

[stocktrademan]

$PTGEF DD Notes ~ http://www.ddnotesmaker.com/PTGEF

bullish

$PTGEF recent news/filings

## source: finance.yahoo.com

Thu, 16 Oct 2014 13:00:00 GMT ~ Portage Completes Non-brokered Private Placement for a Total Proceeds of US$2,000,000

[PR Newswire] - TORONTO, Oct. 16, 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that it has completed its non-brokered private placement raising US$2,000,000 through issuance of 20 million common shares at US$0.10 each. The Company is debt free. The proceeds will be used for further development activities at its two subsidiaries BioHaven and Portage Pharma. The common shares issued are subject to restrictions as applicable under the US and Canadian securities laws.

read full: http://finance.yahoo.com/news/portage-completes-non-brokered-private-130000315.html
*********************************************************

Mon, 06 Oct 2014 13:00:00 GMT ~ Portage announces additional consultants to expedite its PPL-003 development programs

[PR Newswire] - TORONTO, Oct. 6, 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U) , is pleased to announce that its wholly owned ...

read full: http://finance.yahoo.com/news/portage-announces-additional-consultants-expedite-130000967.html
*********************************************************

Mon, 29 Sep 2014 18:11:00 GMT ~ Portage announces conversion of its debt into equity

[PR Newswire] - TORONTO, Sept. 29, 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that its three Promissory Note holders, two of whom are the directors of Portage, who advanced $ 100,000 each in July 2014 for a total of $ 300,000 opted to have their Notes and related Coupons converted into 3,500,001 restricted common shares. Both the Note and the coupon were convertible into common shares to be valued at 10% discount to the current financing at $ 0.10 per share. Following proof of concept, Portage will look to sell or license the products to large pharmaceutical companies for further development and commercialization. Portage is seeking discovery and co-development partners in areas such as cancer, infectious disease, neurology and psychiatry developing novel targeted therapies, stem cell therapy and even older marketed products that have been found to have novel patentable characteristics that bring new value to patients.

read full: http://finance.yahoo.com/news/portage-announces-conversion-debt-equity-181100376.html
*********************************************************

Tue, 23 Sep 2014 13:00:00 GMT ~ Portage Announces New Consultants for its PPL-003 Development Programs

[PR Newswire] - TORONTO, Sept. 23, 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that its wholly owned subsidiary, Portage Pharmaceuticals Ltd (PPL) has added two more consultants to its team for further development of its PPL-003 for uveitis. PPL-003 uses a new proprietary cell permeable peptide platform technology derived from human genes to deliver its anti-inflammatory cargo into the eye. Ms. Holly Prentice who possesses extensive experience and expertise in the field of recombinant drug manufacturing will act as Director of Biotherapeutics Manufacturing and will be focused on developing a GMP process for PPL-003. Ms. Kimberley Gentile, who has over 25 years of experience in all phases of clinical research and operational experience, will act as Director of Operations focused on PPL's uveitis project for PPL-003.

read full: http://finance.yahoo.com/news/portage-announces-consultants-ppl-003-130000711.html
*********************************************************

Thu, 11 Sep 2014 12:57:00 GMT ~ Portage Announces Proposed Private Placement

[PR Newswire] - TORONTO, Sept. 11, 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U) , announces that it intends to conduct a Private ...

read full: http://finance.yahoo.com/news/portage-announces-proposed-private-placement-125700532.html
*********************************************************


$PTGEF charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$PTGEF company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/PTGEF/company-info
Ticker: $PTGEF
OTC Market Place: OTC Pink Current
CIK code: 0001095435
Company name: Portage Biotech Inc
Company website: http://www.portagebiotech.com
Incorporated In: Virgin Islands (British)

Business Description: The Company is engaged in researching and developing pharmaceutical and biotech products through to clinical ?proof of concept? with an initial focus on unmet clinical needs and orphan drugs. Following proof of concept, the Company will look to sell or license the products to large pharmaceutical companies for further development and commercialization. The Company, through its subsidiary, holds an exclusive worldwide licence in non-oncology fields and the know-how relating to the Antennapedia protein transduction technology developed by Trojantec.Less >>


$PTGEF share structure

## source: otcmarkets.com

Market Value: $25,308,611 a/o Oct 20, 2014
Shares Outstanding: 180,775,790 a/o May 24, 2014
Float: 86,333,997 a/o Sep 10, 2013
Authorized Shares: Unlimited a/o May 24, 2014
Par Value: No Par Value
$PTGEF extra dd links

Company name: Portage Biotech Inc
Company website: http://www.portagebiotech.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PTGEF+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PTGEF+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PTGEF+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/news - http://finance.yahoo.com/q/h?s=PTGEF+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PTGEF/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PTGEF+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PTGEF
DTCC (dtcc.com): http://search2.dtcc.com/?q=Portage+Biotech+Inc&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Portage+Biotech+Inc
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Portage+Biotech+Inc&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.portagebiotech.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.portagebiotech.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.portagebiotech.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/PTGEF
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001095435&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=PTGEF&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PTGEF
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PTGEF+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PTGEF+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PTGEF
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PTGEF
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PTGEF+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PTGEF/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PTGEF+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PTGEF.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PTGEF
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PTGEF
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PTGEF
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PTGEF:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PTGEF
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=PTGEF



$PTGEF DD Notes ~ http://www.ddnotesmaker.com/PTGEF